Table 3 Mortality in IgA anti-tTG positive individuals (subgroup analyses)
Subgroup | tTGA+ Deaths | tTGA- Deaths | Adjusted HR; 95 % CI | P value | Absolute risk/1000 PYAR | Excess risk/1000 PYAR |
|---|---|---|---|---|---|---|
Sex | ||||||
Males | 44 | 1535 | 1.69; 1.26–2.29 | 0.001 | 96 | 39 |
Females | 14 | 1461 | 0.96; 0.57–1.62 | 0.881 | 42 | −2 |
Age | ||||||
50–59 years | 3 | 272 | 1.91; 0.61–6.02 | 0.267 | 21 | 10 |
60–69 years | 20 | 766 | 1.58; 1.01–2.47 | 0.044 | 54 | 20 |
70–79 years | 22 | 940 | 1.49; 0.97–2.27 | 0.068 | 103 | 34 |
80+ years | 13 | 1018 | 1.41; 0.81–2.47 | 0.222 | 217 | 63 |
Race | ||||||
Non-Hispanic White | 29 | 1794 | 1.58; 1.09–2.28 | 0.015 | 77 | 28 |
Non-Hispanic Black | 13 | 603 | 1.25; 0.72–2.17 | 0.424 | 68 | 14 |
Mexican-American | 13 | 532 | 1.23; 0.71–2.15 | 0.461 | 68 | 13 |
Other | 3 | 67 | 4.75; 1.45–15.55 | 0.010 | 97 | 76 |